Related Experiment Video

Updated: Aug 18, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Pediatric aspergillosis: disease and treatment differences in children

William J Steinbach1

  • 1Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

The Pediatric Infectious Disease Journal
|April 9, 2005
PubMed

Insights

Pediatric invasive aspergillosis is understudied, with unique diagnostic and antifungal treatment needs distinct from adults. Further research is crucial for effective pediatric patient care.

Area of Science:

  • Medical Mycology
  • Pediatric Infectious Diseases
  • Clinical Research

Background:

  • Invasive aspergillosis is a growing concern, particularly in immunocompromised individuals.
  • Limited specific data exists regarding pediatric invasive aspergillosis.
  • Children present unique challenges due to differing underlying diseases and treatments compared to adults.

Purpose of the Study:

  • To highlight the specific challenges and considerations for pediatric invasive aspergillosis.
  • To emphasize the need for tailored diagnostic and therapeutic approaches in children.
  • To underscore the limitations of adult-focused tools and treatments in pediatric populations.

Main Methods:

  • Review of existing literature on pediatric invasive aspergillosis.
  • Analysis of differences in disease presentation and management between pediatric and adult patients.
  • Evaluation of the applicability of current diagnostic tools and antifungal strategies in children.

Main Results:

  • Pediatric invasive aspergillosis exhibits heterogeneity, influenced by distinct patient populations and treatments.
  • New diagnostic tools, while promising for adults, show limited utility in children without specific validation.
  • Antifungal management in pediatric cases necessitates unique dosing regimens different from adult protocols.

Conclusions:

  • Pediatric invasive aspergillosis requires specialized diagnostic and therapeutic strategies.
  • Current adult-oriented approaches are often inadequate for effective pediatric management.
  • Further research and validation are essential to improve outcomes for children with invasive aspergillosis.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: